Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP740412.RAeTH_B5rwj7EKfLrjXigCvD996Mv7sk_y_n2W1A8cAFI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP740412.RAeTH_B5rwj7EKfLrjXigCvD996Mv7sk_y_n2W1A8cAFI130_assertion type Assertion NP740412.RAeTH_B5rwj7EKfLrjXigCvD996Mv7sk_y_n2W1A8cAFI130_head.
- NP740412.RAeTH_B5rwj7EKfLrjXigCvD996Mv7sk_y_n2W1A8cAFI130_assertion description "[Therefore, the aim of the present study was to examine in the human neuroblastoma SH-SY5Y cell line the impact of a typical (haloperidol) and an atypical (quetiapine) antipsychotic on the expression of genes encoding the key enzymes of the antioxidant metabolism (Cu, Zn superoxide dismutase; Mn superoxide dismutase; glutathione peroxidase; catalase) and enzymes of the glutathione metabolism (gamma-glutamyl cysteine synthetase, glutathione-S-transferase, gamma-glutamyltranspeptidase, glutathione reductase).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740412.RAeTH_B5rwj7EKfLrjXigCvD996Mv7sk_y_n2W1A8cAFI130_provenance.
- NP740412.RAeTH_B5rwj7EKfLrjXigCvD996Mv7sk_y_n2W1A8cAFI130_assertion evidence source_evidence_literature NP740412.RAeTH_B5rwj7EKfLrjXigCvD996Mv7sk_y_n2W1A8cAFI130_provenance.
- NP740412.RAeTH_B5rwj7EKfLrjXigCvD996Mv7sk_y_n2W1A8cAFI130_assertion SIO_000772 19101687 NP740412.RAeTH_B5rwj7EKfLrjXigCvD996Mv7sk_y_n2W1A8cAFI130_provenance.
- NP740412.RAeTH_B5rwj7EKfLrjXigCvD996Mv7sk_y_n2W1A8cAFI130_assertion wasDerivedFrom befree-20140225 NP740412.RAeTH_B5rwj7EKfLrjXigCvD996Mv7sk_y_n2W1A8cAFI130_provenance.
- NP740412.RAeTH_B5rwj7EKfLrjXigCvD996Mv7sk_y_n2W1A8cAFI130_assertion wasGeneratedBy ECO_0000203 NP740412.RAeTH_B5rwj7EKfLrjXigCvD996Mv7sk_y_n2W1A8cAFI130_provenance.